Vibrating Mattress Helps Clear Alzheimer's Protein From the Brain
4 39A vibrating mattress combined with two pills that release nitric oxide enhanced the brain's ability to clear an Alzheimer's-related protein. According to New Scientist, the experiment "caused the brain's blood vessels to swell and constrict more strongly, which enhanced the glymphatic system's clearance of [the protein]." From the report: [Kesa Kiviniemi at the University of Oulu in Finland] and his colleagues recruited 29 adults who hadn't been diagnosed with Alzheimer's disease or any other cognitive issues. The participants took a pill that dissolves when under the tongue, releasing nitric oxide. They then lay on a mattress that caused their bodies to gently vibrate for 40 minutes, taking another pill halfway through. Blood samples revealed that their levels of a type of protein called beta-amyloid 42 increased by 35 per cent, on average, after the intervention. This protein, which usually helps neurons signal and connect to each other, misfolds and form clumps in Alzheimer's disease.
"The treatment seemed to enhance the glymphatic system's ability to clear beta-amyloid from the brain to the blood," says Kiviniemi. "A 35 per cent increase in circulating beta-amyloid 42 is a substantial and very interesting acute effect," says Tuomas Lilius at the University of Helsinki, who wasn't involved in the work. "It is certainly possible it could become biologically, and eventually clinically, relevant." Side effects were mild and minimal, with six of the participants experiencing issues such as nausea and headache. However, this could partly be due to the expectation of an effect from the nitric oxide pills. The researchers hope to overcome this in future work by including placebo pills.
Brain scans suggest the treatment enhanced the flow of fluid along glymphatic channels, probably by widening the brain's blood vessels and making them pump more strongly, says Kiviniemi. But other mechanisms could also be at play, says Brown. For instance, this intervention may slow the breakdown of beta-amyloid 42 by the liver, leading to higher amounts in the bloodstream, he says. Future studies could get around this by injecting markers into cerebrospinal fluid, which moves through the glymphatic system, to more directly measure its flow, says Brown. Additional experiments by Kiviniemi and his colleagues tested either only the mattress vibrations or only the nitric oxide pills on the same participants, at least a week before or after they underwent the combined approach. Based on brain scans, these solo interventions seemed to have less than half the effect on the glymphatic system than when they were combined. The findings have been published in the journal Nature Communications.
4 comments
Magic Fingers was onto something (Score: 5, Funny)
by sinkskinkshrieks ( 6952954 ) on Saturday November 07, 2026 @03:34AM (#66414039)
Insert $ 0.25 to reduce plaque buildup.
Re:Debunked... (Score: 5, Informative)
by Going_Digital ( 1485615 ) on Saturday November 07, 2026 @06:21AM (#66414127)
I don't know about fraudulent, but drugs that reduce beta-amyloid plaques have been developed, but have shown little to no improvement in dementia symptoms. This suggests there may not be a direct causal relationship, and that beta-amyloid may be symptomatic of another cause.
Re:Debunked... (Score: 5, Informative)
by dvice ( 6309704 ) on Saturday November 07, 2026 @07:13AM (#66414155)
You are probably talking about this:
https://katiecouric.com/health... [katiecouric.com].
Lesné’s paper claimed that they found a specific subtype of amyloid protein which causes memory loss. Fraud was that the data was altered using software.
The general link between beta-amyloid and Alzheimer’s still exist in the research.
Methodology (Score: 5, Insightful)
by Jarik C-Bol ( 894741 ) on Saturday November 07, 2026 @07:40AM (#66414167)
It’s rather refreshing to see a medical science article that both admits to the limitations of their study, and lays out a pathway to continue the study and address those limitations. So many ‘medical breakthrough’ articles get published touting some new miracle treatment, only for the reader to find its ‘in mice’ or the study was done without any double blind controls, on a test group of 3 patients, rendering the results anecdotal at best. This article at least admits the limitations of what they have done so far, and appears to propose ways/plans to actually study this correctly.